Dr David Goldfarb is Professor of Medicine and Physiology at the New York University (NYU) Grossman School of Medicine, Clinical Chief of the Nephrology Division at NYU Langone Health, and Chief of the Nephrology Section at the New York VA Medical Center in Manhattan, NY, USA. He serves as the Director of the Kidney Stone Prevention Program at NYU Langone and at New York VA Medical Center.

Dr Goldfarb graduated from Yale College and the Yale School of Medicine, and trained in internal medicine at New York Harbor VA Medical Center and NYU, and in nephrology at NYU. He is the principal investigator of the Rare Kidney Stone Consortium’s cystinuria project, and served as the President of the NY Society of Nephrology (1999) and of the ROCK Society (Research on Calculus Kinetics, 2016). Dr Goldfarb was vice-chair of the American Urological Association’s guideline panel, representing the American Society of Nephrology on Medical Management of Kidney Stones, and co-authored the last set of guidelines.

Dr Goldfarb earned a certificate from the Yale School of Public Health for its course on ‘Climate Change and Health’ in 2023. He was selected as Stone Crusher of the Year in 2014 by the Oxalosis and Hyperoxaluria Foundation, and Nephrologist of the Year in 2016 by the American Kidney Fund. He has had three calcium oxalate stones.